Mitochondria and apoptosis: New therapeutic targets

Advances in Cancer Research

Volumn 85, Issue , 2002, Pages 203-242

  Hockenbery, David M ^a   Giedt, Christopher D ^a   O'Neill, Jason W ^a   Manion, Michael K ^a   Banker, Deborah E ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE; 2 METHOXY ANTIMYCIN A; 2,6 BIS(4 AMINOPHENYL) 4 [4 (4 DIMETHYLAMINO)PHENYL]THIOPYRYLIUM; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADENINE NUCLEOTIDE TRANSLOCASE; ANION CHANNEL; ANTIMYCIN A1; ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BENZOPORPHYRIN DERIVATIVE; BETULIC ACID; CHROMENE DERIVATIVE; COMPOUND 6; CREATINE KINASE; CYCLOPHILIN; CYCLOPHILIN D; DEQUALINIUM; FLUORESCENT DYE; LONIDAMINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; ORGANOARSENIC DERIVATIVE; ORGANOTIN COMPOUND; PROTEIN BCL 2; PROTEIN BCL X; RHODAMINE 123; THIAZOLIDINE DERIVATIVE; TRIBUTYLTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER CELL; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CHANNEL GATING; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION; DRUG STRUCTURE; HUMAN; HUMAN CELL; KIDNEY CANCER; KIDNEY DISEASE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STRUCTURE ANALYSIS;

EID: 0036386545     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-230X(02)85007-2     Document Type: Review

References (203)

1. Anderson, W. M., Patheja, H. S., Delinck, D. L., Baldwin, W. W., Smiley, S. T., and Chen, L. B. (1989). Inhibition of bovine heart mitochondrial and Paracoccus denitrificans NADH - Ubiquinone reductase by dequalinium chloride and three structurally related quinolinium compounds. Biochem. Int. 19, 673-685.
2. Andreeff, M., Jiang, S., Zhang, X., Konopleva, M., Estrov, Z., Snell, V. E., Xie, Z., Okcu, M. F., Sanchez-Williams, G., Dong, J., Estey, E. H., Champlin, R. C., Kornblau, S. M., Reed, J. C., and Zhao, S. (1999). Expression of Bcl-2-related genes in normal and AML progenitors: Changes induced by chemotherapy and retinoic acid. Leukemia 13, 1881-1892.
3. Anholt, R. R., Pedersen, P. L., De Souza, E. B., and Snyder, S. H. (1986). The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261, 576-583.
4. Aquila, H., and Klingenberg, M. (1982). The reactivity of -SH groups in the ADP/ATP carrier isolated from beef heart mitochondria. Eur. J. Biochem. 122, 141-145.
5. Arancia, G., Malorni, W., Trovalusci, P. C., Isacchi, G., Giannella, G., and De Martino, C. (1988). Differential effect of lonidamine on the plasma membrane ultrastructure of normal and leukemic human lymphocytes. Exp. Mol. Pathol. 48, 37-47.
6. Arora, K. K., and Pedersen, P. L. (1988). Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J. Biol. Chem. 263, 17, 422-17, 428.
7. Baggetto, L. G. (1992). Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74, 959-974.
8. Banker, D. E., Cooper, J. J., Fennell, D. A., William, C. L., Appelbaum, E R., and Cotter, F. E. (2002). PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leuk. Res. 26, 91-106.
9. Barath, P., Luciakova, K., Hodny, Z., Li, R., and Nelson, B. D. (1999). The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. Exp. Cell Res. 248, 583-588.
10. Bauer, M. K., Schubert, A., Rocks, O., and Grimm, S. (1999). Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J. Cell Biol. 147, 1493-1502.
11. Belzacq, A. S., El Hamel, C., Vieira, H. L., Cohen, I., Haouzi, D., Metivier, D., Marchetti, P., Brenner, C., and Kroemer, G. (2001a). Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene 20, 7579-7587.
12. Belzacq, A. S., Jacotot, E., Vieira, H. L., Mistro, D., Granville, D. J., Xie, Z., Reed, J. C., Kroemer, G., and Brenner, C. (2001b). Apoptosis induction by the photosensitizer verteporfin: Identification of mitochondrial adenine nucleotide translocator as a critical target. Cancer Res. 61, 1260-1264.
13. Benavides, J., Quarteronet, D., Imbault, F., Malgouris, C., Uzan, A., Renault, C., Dubroeucq, M. C., Gueremy, C., and Le Fur, G. (1983). Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: Kinetic studies and autoradiographic localization. J. Neurochem. 41, 1744-1750.
14. Benson, R. S., Dive, C., and Watson, A. J. (1998). Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP 16-induced apoptosis in CEM cells. Cell Death Differ. 5, 432-439.
15. Bernal, S. D., Lampidis, T. J., McIsaac, R. M., and Chen, L. B. (1983). Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye. Science 222, 169-172.
16. Bernal, S. D., Lampidis, T. J., Summerhayes, I. C., and Chen, L. B. (1982a). Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro. Science 218, 1117-1119.
17. Bernal, S. D., Shapiro, H. M., and Chen, L. B. (1982b). Monitoring the effect of anti-cancer drugs on L1210 cells by a mitochondrial probe, rhodamine-123. Int. J. Cancer 30, 219-224.
18. Bernardi, P., Scorrano, L., Colonna, R., Petronilli, V., and Di Lisa, F. (1999). Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem. 264, 687-701.
19. Bernardi, P., Vassanelli, S., Veronese, P., Colonna, R., Szabo, I., and Zoratti, M. (1992). Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267, 2934-2939.
20. Beutner, G., Ruck, A., Riede, B., and Brdiczka, D. (1998). Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim. Biophys. Acta 1368, 7-18.
21. Beyer, K., and Klingenberg, M. (1985). ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31P nuclear magnetic resonance. Biochemistry 24, 3821-3826.
22. Bleday, R., Weiss, M. J., Salem, R. R., Wilson, R. E., Chen, L. B., and Steele, G., Jr. (1986). Inhibition of rat colon tumor isograft growth with dequalinium chloride. Arch. Surg. 121, 1272-1275.
23. Block, M. R., and Vignais, P. V. (1986). Dependence of the conformational state of the isolated adenine nucleotide carrier protein on the detergent used for solubilization. Biochemistry 25, 374-379.
24. Bojes, H. K., Feng, X., Kehrer, J. P., and Cohen, G. M. (1999). Apoptosis in hematopoietic cells (FL5.12) caused by interleukin-3 withdrawal: Relationship to caspase activity and the loss of glutathione. Cell Death Differ. 6, 61-70.
25. Bradham, C. A., Qian, T., Streetz, K., Trautwein, C., Brenner, D. A., and Lemasters, J. J. (1998). The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18, 6353-6364.
26. Braestrup, C., and Squires, R. F. (1977). Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc. Natl. Acad. Sci. USA 74, 3805-3809.
27. Bram, R. J., Hung, D. T., Martin, P. K., Schreiber, S. L., and Crabtree, G. R. (1993). Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FKS06: Roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13, 4760-4769.
28. Britten, C. D., Rowinsky, E. K., Baker, S. D., Weiss, G. R., Smith, L., Stephenson, J., Rothenberg, M., Smetzer, L., Cramer, J., Collins, W., Von Hoff, D. D., and Eckhardt, S. G. (2000). A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077. Clin. Cancer Res. 6, 42-49.
29. Brown, J., Higo, H., McKalip, A., and Herman, B. (1997). Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: Role of p53, ICE-like proteases and the mitochondrial permeability transition. J. Cell Biochem. 66, 245-255.
30. Brunet, C. L., Gunby, R. H., Benson, R. S., Hickman, J. A., Watson, A. J., and Brady, G. (1998). Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers. Cell Death Differ. 5, 107-115.
31. 2+. Biochemistry 35, 8483-8488.
32. Buchanan, B. B., Eiermann, W., Riccio, P., Aquila, H., and Klingenberg, M. (1976). Antibody evidence for different conformational states of ADP, ATP translocator protein isolated from mitochondria. Proc. Natl. Acad. Sci. USA 73, 2280-2284.
33. Bustamante, E., and Pedersen, P. L. (1980). Mitochondrial hexokinase of rat hepatoma cells in culture: Solubilization and kinetic properties. Biochemistry 19, 4972-4977.
34. Campo, M. L., Kinnally, K. W., and Tedeschi, H. (1992). The effect of antimycin A on mouse liver inner mitochondrial membrane channel activity. J. Biol. Chem. 267, 8123-8127.
35. Capuano, E, Guerrieri, F., and Papa, S. (1997). Oxidative phosphorylation enzymes in normal and neoplastic cell growth. J. Bioenerg. Biomembr. 29, 379-384.
36. Capuano, F., Varone, D., D'Eri, N., Russo, E., Tommasi, S., Montemurro, S., Prete, F., and Papa, S. (1996). Oxidative phosphorylation and F(O)F(1) ATP synthase activity of human hepatocellular carcinoma. Biochem. Mol. Biol. Int. 38, 1013-1022.
37. Carayon, P., Portier, M., Dussossoy, D., Bord, A., Petitpretre, G., Canat, X., Le Fur, G., and Casellas, P. (1996). Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 87, 3170-3178.
38. Carpentieri, U., and Sordahl, L. A. (1975). Functional properties of mitochondria isolated from murine L5178 lymphoblasts grown in cell culture. Cancer Res. 35, 3636-3641.
39. Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J. L., Nunez, G., Dalton, W. S., and Jove, R. (1999). Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115.
40. Chernyak, B. V., and Bernardi, P. (1996). The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur. J. Biochem. 238, 623-630.
41. Chesney, J., Mitchell, R., Benigni, F., Bacher, M., Spiegel, L., Al-Abed, Y., Han, J. H., Metz, C., and Bucala, R. (1999). An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect. Proc. Natl. Acad. Sci. USA 96, 3047-3052.
42. Chou, J. J., Li, H., Salvesen, G. S., Yuan, J., and Wagner, G. (1999). Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615-624.
43. Coller, H. A., Khrapko, K., Bodyak, N. D., Nekhaeva, E., Herrero-Jimenez, P., and Thilly, W. G. (2001). High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat. Genet. 28, 147-150.
44. Colombini, M., Yeung, C. L., Tung, J., and König, T. (1987). The mitochondrial outer membrane channel, VDAC, is regulated by a synthetic polyanion. Biochim. Biophys. Acta 905,279-286.
45. Connern, C. P., and Halestrap, A. P. (1994). Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302 (Pt 2), 321-324.
46. Cornu, P., Benavides, J., Scatton, B., Hauw, J. J., and Philippon, J. (1992). Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study. Acta Neurochir. (Wien) 119, 146-152.
47. Costantini, P., Belzacq, A. S., Vieira, H. L., Larochette, N., de Pablo, M. A., Zamzami, N., Susin, S. A., Brenner, C., and Kroemer, G. (2000). Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 19, 307-314.
48. Costantini, P., Chernyak, B. V., Petronilli, V., and Bernardi, P. (1996). Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271, 6746-6751.
49. Crabtree, H. G. (1929). Observation on the carbohydrate metabolism of tumors. Biochem. J. 23, 536-545.
50. Crompton, M. (2000). Mitochondrial intermembrane junctional complexes and their role in cell death. J. Physiol 529 (Pt 1), 11-21.
51. +--dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255, 357-360.
52. Crompton, M., Virji, S., and Ward, J. M. (1998). Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258, 729-735.
53. Dalton, W. S., and Jove, R. (1999). Drug resistance in multiple myeloma: Approaches to circumvention. Semin. Oncol. 26, 23-27.
54. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J., and Chen, L. B. (1985). Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 260, 13, 844-13, 850.
55. Decaudin, D., Geley, S., Hirsch, T., Castedo, M., Marchetti, P., Macho, A., Kofler, R., and Kroemer, G. (1997). Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57, 62-67.
56. Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., and Yuan, J. (2001). Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat. Cell Biol. 3, 173-182.
57. de Heredia, M. L., Izquierdo, J. M., and Cuezva, J. M. (2000). A conserved mechanism for controlling the translation of beta-F1-ATPase mRNA between the fetal liver and cancer cells. J. Biol. Chem. 275, 7430-7437.
58. Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., and Martinou, J. C. (1999). Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144, 891-901.
59. Dolder, M., Wendt, S., and Wallimann, T. (2001). Mitochondrial creatine kinase in contact sites: Interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol. Signals Recept. 10, 93-111.
60. Eigenbrodt, E., Reinacher, M., Scheefers-Borchel, U., Scheefers, H., and Friis, R. (1992). Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit. Rev. Oncog. 3, 91-115.
61. Elson, D. A., Ryan, H. E., Snow, J. W., Johnson, R., and Arbeit, J. M. (2000). Coordinate upregulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multistage epidermal carcinogenesis and wound healing. Cancer Res. 60, 6189-6195.
62. Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., Long, Y. Q., Roller, P. P., Yang, D., and Wang, S. (2001). Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J. Med. Chem. 44, 4313-4324.
63. 2+ ions. J. Cell Biol. 143, 217-224.
64. Eskes, R., Desagher, S., Antonsson, B., and Martinou, J. C. (2000). Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20, 929-935.
65. 2+ threshold for the mitochondrial permeability transition and the content of proteins related to Bcl-2 in rat liver and Zajdela hepatoma mitochondria. Mol. Cell. Biochem. 194, 251-256.
66. Fennell, D. A., Corbo, M., Pallaska, A., and Cotter, F. E. (2001). Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. Br. J. Cancer 84, 1397-1404.
67. Fontaine, E., Eriksson, O., Ichas, F., and Bernardi, P. (1998). Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I. J. Biol. Chem. 273, 12, 662-12, 668.
68. Fournier, N., Ducet, G., and Crevat, A. (1987). Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19, 297-303.
69. Fulda, S., Scaffidi, C., Susin, S. A., Krammer, P. H., Kroemer, G., Peter, M. E., and Debatin, K. M. (1998). Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. Biol. Chem. 273, 33, 942-33, 948.
70. Gauthier, E. R., Piche, L., Lemieux, G., and Lemieux, R. (1996). Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Cancer Res. 56, 1451-1456.
71. Gellerich, F.N., Trumbeckaite, S., Opalka, J. R., Seppet, E., Rasmussen, H. N., Neuhoff, C., and Zierz, S. (2000). Function of the mitochondrial outer membrane as a diffusion barrier in health and diseases. Biochem. Soc. Trans. 28, 164-169.
72. Goldman, R. D., Kaplan, N. O., and Hall, T. C. (1964). Lactic dehydrogenase in human neoplastic tissue. Cancer Res. 24, 389-399.
73. Goping, I. S., Gross, A., Lavoie, J. N., Nguyen, M., Jemmerson, R., Roth, K., Korsmeyer, S. J., and Shore, G. C. (1998). Regulated targeting of BAX to mitochondria. J. Cell Biol. 143, 207-215.
74. Gornicki, A., and Gutsze, A. (2001). In vivo and in vitro influence of etretinate on erythrocyte membrane fluidity. Eur. J. Pharmacol. 423, 127-134.
75. Gross, M., and Wallimann, T. (1993). Kinetics of assembly and dissociation of the mitochondrial creatine kinase octamer. A fluorescence study. Biochemistry 32, 13,933-13,940.
76. Hail, N., Jr., Youssef, E. M., and Lotan, R. (2001). Evidence supporting a role for mitochondrial respiration in apoptosis induction by the synthetic retinoid CD437. Cancer Res. 61, 6698-6702.
77. Harada, N., Hata, H., Yoshida, M., Soniki, T., Nagasaki, A., Kuribayashi, N., Kimura, T., Matsuzaki, H., and Mitsuya, H. (1998). Expression of Bcl-2 family of proteins in fresh myeloma cells. Leukemia 12, 1817-1820.
78. Hardwick, M., Fertikh, D., Culty, M., Li, H., Vidic, B., and Papadopoulos, V. (1999). Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59, 831-842.
79. Hennet, T., Bertoni, G., Richter, C., and Peterhans, E. (1993). Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53, 1456-1460.
80. Hirsch, T., Decaudin, D., Susin, S. A., Marchetti, P., Larochette, N., Resche-Rigon, M., and Kroemer, G. (1998). PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp. Cell Res. 241, 426-434.
81. Hirsch, T., Marchetti, P., Susin, S. A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M., and Kroemer, G. (1997). The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 1573-1581.
82. Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., and Korsmeyer, S. J. (1993). Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
83. Hofhaus, G., and Gattermann, N. (1999). Mitochondria harbouring mutant mtDNA - A cuckoo in the nest? Biol. Chem. 380, 871-877.
84. Holinger, E. P., Chittenden, T., and Lutz, R. J. (1999). Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274, 13, 298-13, 304.
85. Holmes, P. V., and Drugan, R. C. (1991). Differential effects of anxiogenic central and peripheral benzodiazepine receptor ligands in tests of learning and memory. Psychopharmacology (Berl) 104, 249-254.
86. Horn, A., Reymann, S., and Thinnes, F. P. (1998). Studies on human porin. XVI: Polyamines reduce the voltage dependence of human VDAC in planar lipid bilayers - Spermine and spermidine inducing asymmetric voltage gating on the channel. Mol. Genet. Metab. 63, 239-242.
87. Huang, Z. (2000). Bcl-2 family proteins as targets for anticancer drug design. Oncogene 19, 6627-6631.
88. Jacotot, E., Ferri, K. F., El Hamel, C., Brenner, C., Druillennec, S., Hoebeke, J., Rustin, P., Metivier, D., Lenoir, C., Gueskens, M., Vieira, H. L., Loeffler, M., Belzacq, A. S., Briand, J. P., Zamzami, N., Edelman, L., Xie, Z. H., Reed, J. C., Roques, B. P., and Kroemer, G. (2001). Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J. Exp. Med. 193, 509-519.
89. Jacotot, E., Ravagnan, L., Loeffler, M., Ferri, K. F., Vieira, H. L., Zamzami, N., Costantini, P., Druillennec, S., Hoebeke, J., Briand, J. P., Irinopoulou, T., Daugas, E., Susin, S. A., Cointe, D., Xie, Z. H., Reed, J. C., Roques, B. P., and Kroemer, G. (2000). The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191, 33-46.
90. Johnson, L. V., Walsh, M. L., Bockus, B. J., and Chen, L. B. (1981). Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J. Cell Biol. 88, 526-535.
91. Johnson, L. V., Walsh, M. L., and Chen, L. B. (1980). Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. USA 77, 990-994.
92. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T., and Bredesen, D. E. (1993). Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262, 1274-1277.
93. Katz, Y., Ben-Baruch, G., Kloog, Y., Menczer, J., and Gavish, M. (1990). Increased density of peripheral benzodiazepine-binding sites in ovarian carcinomas as compared with benign ovarian tumours and normal ovaries. Clin. Sci. (Lond) 78, 155-158.
94. Kawakami, M., Koya, K., Ukai, T., Tatsuta, N., Ikegawa, A., Ogawa, K., Shishido, T., and Chen, L. B. (1998). Structure-activity of novel rhodacyanine dyes as antitumor agents. J. Med. Chem. 41, 130-142.
95. Khaled, A. R., Kim, K., Hofmeister, R., Muegge, K., and Durum, S. K. (1999). Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc. Natl. Acad. Sci. USA 96, 14, 476-14, 481.
96. Kim, K. M., Giedt, C. D., Basanez, G., O'Neill, J. W., Hill, J. J., Han, Y.-H., Tzung, S.-P., Zimmerberg, J., Hockenbery, D. M., and Zhang, K. Y. J. (2001). Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A. Biochemistry 40, 4911-4922.
97. Kinnally, K. W., Zorov, D. B., Antonenko, Y. N., Snyder, S. H., McEnery, M. W., and Tedeschi, H. (1993). Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc. Natl. Acad. Sci. USA 90, 1374-1378.
98. Korsmeyer, S. J., Wei, M. C., Saito, M., Weiler, S., Oh, K. J., and Schlesinger, P. H. (2000). Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 7, 1166-1173.
99. Kress, S., Stein, A., Maurer, P., Weber, B., Reichert, J., Buchmann, A., Huppert, P., and Schwarz, M. (1998). Expression of hypoxia-inducible genes in tumor cells. J. Cancer Res. Clin. Oncol. 124, 315-320.
100. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. (1998). The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642.
101. Kuntz, I. D. (1992). Structure-based strategies for drug design and discovery. Science 257, 1078-1082.
102. Landau, B. R., Laszlo, J., Stengle, J., and Burk, D. (1958). Certain metabolic and pharmacologic effects in cancer patients given infusions of 2-deoxy-D-glucose. J. Natl. Cancer Inst. 21, 485-494.
103. Lampidis, T. J., Bernal, S. D., Summerhayes, I. C., and Chen, L. B. (1983). Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res. 43, 716-720.
104. Larochette, N., Decaudin, D., Jacotot, E., Brenner, C., Marzo, I., Susin, S. A., Zamzami, N., Xie, Z., Reed, J., and Kroemer, G. (1999). Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res. 249, 413-421.
105. Lemasters, J. J., Nieminen, A. L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A., and Herman, B. (1998). The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196.
106. Li, H., and Papadopoulos, V. (1998). Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991-4997.
107. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86, 147-157.
108. Liu, D., and Huang, Z. (2001). Synthetic peptides and non-peptidic molecules as probes of structure and function of Bcl-2 family proteins and modulators of apoptosis. Apoptosis 6, 453-462.
109. Malorni, W., Arancia, G., De Martino, C., Nista, A., Accinni, L., Masella, R., and Cantafora, A. (1988). On the mechanism of action of lonidamine: A study on human erythrocyte membrane. Exp. Mol. Pathol. 49, 361-372.
110. Mancini, M., Anderson, B. O., Caldwell, E., Sedghinasab, M., Paty, P. B., and Hockenbery, D. M. (1997). Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell Biol. 138, 449-469.
111. Mannella, C. A. (1997). Minireview: On the structure and gating mechanism of the mitochondrial channel, VDAC. J. Bioenerg. Biomembr. 29, 525-531.
112. Maruta, H., Tikoo, A., Shakri, R., and Shishido, T. (1999). The anti-RAS cancer drug MKT-077 is an F-actin cross-linker. Ann. NY Acad. Sci. 886, 283-284.
113. Mather, M., and Rottenberg, H. (2001). Polycations induce the release of soluble intermembrane mitochondrial proteins. Biochim. Biophys. Acta 1503, 357-368.
114. Mattevi, A., Bolognesi, M., and Valentini, G. (1996). The allosteric regulation of pyruvate kinase. FEBS Lett. 389, 15-19.
115. Mayaux, J. F., Bousseau, A., Pauwels, R., Huet, T., Henin, Y., Dereu, N., Evers, M., Soler, F., Poujade, C., De Clercq, E., et al. (1994). Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc. Natl. Acad. Sci. USA 91, 3564-3568.
116. McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J., and Cowburn, D. (1999). Solution structure of the proapoptotic molecule BID: A structural basis for apoptotic agonists and antagonists. Cell 96, 625-634.
117. McEnery, M. W., Snowman, A. M., Trifiletti, R. R., and Snyder, S. H. (1992). Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA 89, 3170-3174.
118. Melzig, M. F., and Bormann, H. (1998). Betulinic acid inhibits aminopeptidase N activity. Planta Med. 64, 655-657.
119. Minn, A. J., Velez, P., Schendel, S. L., Liang, H., Muchmore, S. W., Fesik, S. W., Fill, M., and Thompson, C. B. (1997). Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 385, 353-357.
120. Miyoshi, H., Tokutake, N., Imaeda, Y., Akagi, T., and Iwamura, H. (1995). A model of antimycin A binding based on structure-activity studies of synthetic antimycin A analogues. Biochim. Biophys. Acta 1229, 149-154.
121. Modica-Napolitano, J. S., and Aprille, J. R. (2001). Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Deliv. Rev. 49, 63-70.
122. Modica-Napolitano, J. S., Steele, G. D., Jr., and Chen, L. B. (1989). Aberrant mitochondria in two human colon carcinoma cell lines. Cancer Res. 49, 3369-3373.
123. Modica-Napolitano, J. S., Weiss, M. J., Chen, L. B., and Aprille, J. R. (1984). Rhodamine 123 inhibits bioenergetic function in isolated rat liver mitochondria. Biochem. Biophys. Res. Commun. 118, 717-723.
124. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. L., and Fesik, S. W. (1996). X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341.
125. Naasani, I., Seimiya, H., Yamori, T., and Tsuruo, T. (1999). FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis. Cancer Res. 59, 4004-4011.
126. Nakayama, K., Okamoto, E, and Harada, Y. (1956). Antimycin A: Isolation from a new streptomyces and activity against rice plant blast fungi. J. Antibiotics Japan Ser. A 9, 63-66.
127. Nelson, A. (2001). Conducting gramicidin channel activity in phospholipid monolayers. Biophys. J. 80, 2694-2703.
128. Nicolaou, K., Pfefferkorn, J., Schuler, E, Roecker, A., Cao, G., and Casida, J. (2000). Combinatorial synthesis of novel and potent inhibitors of NADH: ubiquinone oxidoreductase. Chem. Biol. 7, 979-992.
129. Nicolli, A., Basso, E., Petronilli, V., Wenger, R. M., and Bernardi, P. (1996). Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel. J. Biol. Chem. 271, 2185-2192.
130. Nishikimi, A., Kira, Y., Kasahara, E., Sato, E. F., Kanno, T., Utsumi, K., and Inoue, M. (2001). Tributyltin interacts with mitochondria and induces cytochrome c release. Biochem. J. 356, 621-626.
131. Noma, T., Song, S., Yoon, Y. S., Tanaka, S., and Nakazawa, A. (1998). cDNA cloning and tissue-specific expression of the gene encoding human adenylate kinase isozyme 2. Biochim. Biophys. Acta 1395, 34-39.
132. Nooter, K., Oostrum, R., Jonker, R., van Dekken, H., Stokdijk, W., and van den Engh, G. (1989). Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry. Cancer Chemother. Pharmacol. 23, 296-300.
133. Nunez, G., Benedict, M. A., Hu, Y., and Inohara, N. (1998). Caspases: The proteases of the apoptotic pathway. Oncogene 17, 3237-3245.
134. O'Gorman, E., Beutner, G., Dolder, M., Koretsky, A. P., Brdiczka, D., and Wallimann, T. (1997). The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414, 253-257.
135. Papadopoulos, V., Amri, H., Li, H., Boujrad, N., Vidic, B., and Garnier, M. (1997). Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 272, 32,129-32,135.
136. Pastorino, J. G., Chen, S. T., Tafani, M., Snyder, J. W., and Farber, J. L. (1998). The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273, 7770-7775.
137. Payne, R. M., and Strauss, A. W. (1994). Expression of the mitochondrial creatine kinase genes. Mol. Cell. Biochem. 133-134, 235-243.
138. Pedersen, P. L., Eska, T., Morris, H. P., and Catterall, W. A. (1971). Deficiency of uncoupler-stimulated adenosine triphosphatase activity in tightly coupled hepatoma mitochondria. Proc. Natl. Acad. Sci. USA 68, 1079-1082.
139. 2+ efflux from pig heart mitochondria. Biochim. Biophys. Acta 462, 403-413.
140. Penta, J. S., Johnson, F. M., Wachsman, J. T., and Copeland, W. C. (2001). Mitochondrial DNA in human malignancy. Mutat. Res. 488, 119-133.
141. Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., and Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130, 157-167.
142. Petronilli, V., Cola, C., Massari, S., Colonna, R., and Bernardi, P. (1993). Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J. Biol. Chem. 268, 21,939-21,945.
143. Petronilli, V., Costantini, P., Scorrano, L., Colonna, R., Passamonti, S., and Bernardi, P. (1994). The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269, 16,638-16,642.
144. Petrucci, D., Cesare, P., and Colafarina, S. (1997). Mitochondria, hexokinase and pyruvate kinase isozymes in the aerobic glycolysis of tumor cells. Ital. J. Biochem. 46, 131-141.
145. Pisha, E., Chai, H., Lee, I. S., Chagwedera, T. E., Farnsworth, N. R., Cordell, G. A., Beecher, C. W., Fong, H. H., Kinghorn, A. D., Brown, D. M., et al. (1995). Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1, 1046-1051.
146. Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K., Markowitz, S. D., Trush, M. A., Kinzler, K. W., and Vogelstein, B. (1998). Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 20, 291-293.
147. Preston, T. J., Abadi, A., Wilson, L., and Singh, G. (2001). Mitochondrial contributions to cancer cell physiology: Potential for drug development. Adv. Drug Delivery Rev. 49, 45-61.
148. Propper, D. J., Braybrooke, J. P., Taylor, D. J., Lodi, R., Styles, P., Cramer, J. A., Collins, W. C., Levitt, N. C., Talbot, D. C., Ganesan, T. S., and Harris, A. L. (1999). Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours. Ann. Oncol. 10, 923-927.
149. Puthier, D., Derenne, S., Barille, S., Moreau, P., Harousseau, J. L., Bataille, R., and Amiot, M. (1999). Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br. J. Haematol. 107, 392-395.
150. Racker, E. (1983). Resolution and reconstitution of biological pathways from 1919 to 1984. Fed. Proc. 42, 2899-2909.
151. Ruffolo, S. C., Breckenridge, D. G., Nguyen, M., Goping, I. S., Gross, A., Korsmeyer, S. J., Li, H., Yuan, J., and Shore, G. C. (2000). BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death Differ. 7, 1101-1108.
152. Rustenbeck, I., Loptien, D., Fricke, K., Lenzen, S., and Reiter, H. (1998). Polyamine modulation of mitochondrial calcium transport. II. Inhibition of mitochondrial permeability transition by aliphatic polyamines
153. Salomon, A. R., Voehringer, D. W., Herzenberg, L. A., and Khosla, C. (2000). Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase. Proc. Natl. Acad. Sci. USA 97, 14,766-14,771.
154. Salvesen, G. S., and Dixit, V. M. (1997). Caspases: Intracellular signaling by proteolysis. Cell 91, 443-446.
155. Santini, M. T., Cametti, C., Indovina, P. L., Malorni, W., Benassi, M., Gentile, F. P., Castiglione, S., and Floridi, A. (1991). Effects of lonidamine on the membrane electrical properties of Ehrlich ascites tumor cells. FEBS Lett. 291, 169-172.
156. Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., Thompson, C. B., and Fesik, S. W. (1997). Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-986.
157. Scheffler, I. E. (2001). Mitochondria make a come back. Adv. Drug Delivery Rev. 49, 3-26.
158. Schendel, S. L., Xie, Z., Montal, M. O., Matsuyama, S., Montal, M., and Reed, J. C. (1997). Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94, 5113-5118.
159. Schlattner, U., Dolder, M., Wallimann, T., and Tokarska-Schlattner, M. (2001). Mitochondrial creatine kinase and mitochondrial outer membrane porin show a direct interaction that is modulated by calcium. J. Biol. Chem. 276, 48,027-48,030.
160. Schuler, W., Wecker, K., de Rocquigny, H., Baudat, Y., Sire, J., and Roques, B. P. (1999). NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: Molecular insights into its biological functions. J. Mol. Biol. 285, 2105-2117.
161. Schwarze, M. M., and Hawley, R. G. (1995). Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL. Cancer Res. 55, 2262-2265.
162. Shim, H., Chun, Y. S., Lewis, B. C., and Dang, C. V. (1998). A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95, 1511-1516.
163. Shim, H., Dolde, C., Lewis, B. C., Wu, C. S., Dang, G., Jungmann, R. A., Dalla-Favera, R., and Dang, C. V. (1997). c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94, 6658-6663.
164. Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H. G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., Green, D. R., and Martin, S. J. (1999). Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292.
165. Smiley, S. T., Reers, M., Mottola-Hartshorn, C., Lin, M., Chen, A., Smith, T. W., Steele, G. D., Jr., and Chen, L. B. (1991). Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc. Natl. Acad. Sci. USA 88, 3671-3675.
166. Smith, T. A. (2000). Mammalian hexokinases and their abnormal expression in cancer. Br. J. Biomed. Sci. 57, 170-178.
167. Snyder, S. H., Verma, A., and Trifiletti, R. R. (1987). The peripheral-type benzodiazepine receptor: A protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. Faseb J. 1, 282-288.
168. Soignet, S. L., Frankel, S. R., Douer, D., Tallman, M. S., Kantarjian, H., Calleja, E., Stone, R. M., Kalaycio, M., Scheinberg, D. A., Steinherz, P., Sievers, E. L., Coutre, S., Dahlberg, S., Ellison, R., and Warrell, R. P., Jr. (2001). United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol. 19, 3852-3860.
169. Stefanelli, C., Stanic, I., Zini, M., Bonavita, F., Flamigni, F., Zambonin, L., Landi, L., Pignatti, C., Guarnieri, C., and Caldarera, C. M. (2000). Polyamines directly induce release of cytochrome c from heart mitochondria. Biochem. J. 347 (Pt 3), 875-880.
170. Stepien, G., Torroni, A., Chung, A. B., Hodge, J. A., and Wallace, D. C. (1992). Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during muscle cell differentiation. J. Biol. Chem. 267, 14,592-14,597.
171. Stewart, M. J., and Steenkamp, V. (2000). The biochemistry and toxicity of atractyloside: A review. Ther. Drug Monit. 22, 641-649.
172. Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepherd, E. L., and Chen, L. B. (1982). Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA 79, 5292-5296.
173. Sun, X., Wong, J. R., Song, K., Hu, J., Garlid, K. D., and Chen, L. B. (1994). AA1, a newly synthesized monovalent lipophilic cation expresses potent in vivo antitumor activity. Cancer Res. 54, 1465-1471.
174. Suzuki, M., Youle, R. J., and Tjandra, N. (2000). Structure of Bax: Coregulation of dimer formation and intracellular localization. Cell 103, 645-654.
175. Tepper, A. D., de Vries, E., van Blitterswijk, W. J., and Borst, J. (1999). Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J. Clin. Invest. 103, 971-978.
176. Thornberry, N. A., and Lazebnik, Y. (1998). Caspases: Enemies within. Science 281, 1312-1316.
177. Tokutake, N., Miyoshi, H., Satoh, T., Hatano, T., and Iwamura, H. (1994). Structural factors of antimycin A molecule required for inhibitory action. Biochim. Biophys. Acta 1185, 271-278.
178. Tu, Y., Renner, S., Xu, F., Fleishman, A., Taylor, J., Weisz, J., Vescio, R., Rettig, M., Berenson, J., Krajewski, S., Reed, J. C., and Lichtenstein, A. (1998). BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res. 58, 256-262.
179. Tzung, S. P., Kim, K. M., Basanez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y., and Hockenbery, D. M. (2001). Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. Nat. Cell Biol. 3, 183-191.
180. Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T., and Thompson, C. B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
181. Vora, S., Halper, J. P., and Knowles, D. M. (1985). Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: Transformation- and progression-linked discriminants of malignancy. Cancer Res. 45, 2993-3001.
182. Vyssokikh, M. Y., Katz, A., Rueck, A., Wuensch, C., Dorner, A., Zorov, D. B., and Brdiczka, D. (2001). Adenine nucleotide translocator isoforms 1 and 2 are differently distributed in the mitochondrial inner membrane and have distinct affinities to cyclophilin D. Biochem. J. 358, 349-358.
183. Wadhwa, R., Sugihara, T., Yoshida, A., Nomura, H., Reddel, R. R., Simpson, R., Maruta, H., and Kaul, S. C. (2000). Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res. 60, 6818-6821.
184. Walter, L., Nogueira, V., Leverve, X., Heitz, M. P., Bernardi, P., and Fontaine, E. (2000). Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J. Biol. Chem. 275, 29,521-29,527.
185. Wang, J. L., Liu, D., Zhang, Z. J., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., and Huang, Z. (2000). Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl. Acad. Sci. USA 97, 7124-7129.
186. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314.
187. Warburg, O. H., Posener, K., and Negelein, E. (1924). Über den Stoffwechsel der Karzinomzelle. Biochem. Zeitschr. 152, 309-44.
188. Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., Jr., and Chen, L. B. (1987). Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc. Natl. Acad. Sci. USA 84, 5444-5448.
189. Wilson, M. R. (1998). Apoptosis: Unmasking the executioner. Cell Death Differ. 5, 646-652.
190. Woodfield, K., Ruck, A., Brdiczka, D., and Halestrap, A. P. (1998). Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 336 (Pt 2), 287-290.
191. Woodfield, K. Y., Price, N. T., and Halestrap, A. P. (1997). cDNA cloning of rat mitochondrial cyclophilin. Biochim. Biophys. Acta. 1351, 27-30.
192. Wu, J. C., Merlino, G., Cveklova, K., Mosinger, B., Jr., and Fausto, N. (1994). Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Cancer Res. 54, 5964-5973.
193. Xiang, J., Chao, D. T., and Korsmeyer, S. J. (1996). BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 14,559-14,563.
194. Yamada, K., and Noguchi, T. (1999). Regulation of pyruvate kinase M gene expression. Biochem. Biophys. Res. Commun. 256, 257-262.
195. Yamamoto, T., Seino, Y., Fukumoto, H., Koh, G., Yano, H., Inagaki, N., Yamada, Y., Inoue, K., Manabe, T., and Imura, H. (1990). Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 170, 223-230.
196. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
197. Yeliseev, A. A., Krueger, K. E., and Kaplan, S. (1997). A mammalian mitochondrial drug receptor functions as a bacterial "oxygen" sensor. Proc. Natl. Acad. Sci. USA 94, 5101-5106.
198. Younes, M., Lechago, L. V., Somoano, J. R., Mosharaf, M., and Lechago, J. (1996). Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res. 56, 1164-1167.
199. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., and Kroemer, G. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
200. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kroemer, G. (1996). Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533-1544.
201. Zang, Y., Beard, R. L., Chandraratna, R. A., and Kang, J. X. (2001). Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ. 8, 477-485.
202. Zhou, R., Bansal, N., Leeper, D. B., and Glickson, J. D. (2000). Intracellular acidification of human melanoma xenografts by the respiratory inhibitor m-iodobenzylguanidine plus hyperglycemia: A 31P magnetic resonance spectroscopy study. Cancer Res. 60, 3532-3536.
203. Zuco, V., Supino, R., Righetti, S. C., Cleris, L., Marchesi, E., Gambacorti-Passerini, C., and Formelli, F. (2002). Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 175, 17-25.